TABLE 1.
Treatment of MtbWL | Expansion indexa | % inhibitionb | % inhibition × EI | Sp actc |
---|---|---|---|---|
None | 10.84 ± 5.740 | 71.39 ± 13.03 | 773.87 | 71.01 |
Reduction and alkylation | 7.14 ± 2.56 | 66.63 ± 12.11 | 475.74 | 47.55 |
Delipidation | 27.87 ± 8.30 | 69.04 ± 5.17 | 1,924.14 | 12.45 |
RNase and DNase digestion | 14.27 ± 5.820 | 82.57 ± 2.760 | 1,178.27 | 12.58 |
Base hydrolysis | 28.35 ± 10.58 | 74.5 ± 6.86 | 2,112.08 | 11.89 |
Acid hydrolysis | 2.98 ± 1.96 | −10.55 ± 0.28 | −31.44 | 0.68 |
Pronase digestion | 35.04 ± 11.15 | 64.22 ± 6.400 | 2,250.27 | 12.81 |
Trypsin digestion | 13.16 ± 1.840 | 67.76 ± 10.80 | 891.72 | 5.90 |
Expansion index is calculated as the fold expansion of the absolute number of γ9δ2 T cells after stimulation with treated lysates compared to the absolute number of γ9δ2 T cells after rest in medium. Results are presented as means ± SE.
Percent inhibition is calculated as described in Materials and Methods. Results are presented as means ± SE.
Specific activity is calculated as (percent inhibition × EI)/dry weight of the material.